Myriad Genetics MYGN EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Myriad Genetics’s reported figures.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's EBITDA?
- Myriad Genetics (MYGN) reported EBITDA of -$18.2M in Q1 2026.
- How has Myriad Genetics's EBITDA changed year-over-year?
- Myriad Genetics's EBITDA decreased by 24.7% year-over-year, from -$14.6M to -$18.2M.
- What is the long-term trend for Myriad Genetics's EBITDA?
- Over 4 years (2021 to 2025), Myriad Genetics's EBITDA has grown at a 27.1% compound annual growth rate (CAGR), from -$127.7M to -$333.5M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.